CXO MovesAI Leadership & Strategy
EY Appoints Luke Dunlap as Managing Director in R&D Strategy and Transformation
Article content
EY has appointed Luke Dunlap as Managing Director in its R&D Strategy and Transformation team, reinforcing the firm's advisory capabilities for life sciences organizations as the industry increasingly embraces AI, automation, and digital transformation.
The appointment supports EY's continued investment in helping pharmaceutical and biotechnology companies modernize research and development to accelerate innovation and improve patient outcomes.
Driving the Future of Life Sciences Innovation
Announcing the move on LinkedIn, Luke shared his excitement about joining EY and continuing his mission of helping life sciences organizations transform the way they discover, develop, and deliver innovative therapies.
He noted that throughout his career, he has been passionate about enabling organizations to improve R&D performance and expressed enthusiasm about joining EY's team to advance that work on a broader scale.
Leading R&D Strategy and Transformation
As Managing Director, Luke will partner with life sciences clients to transform R&D strategy, automation, operational processes, and AI capabilities.
His focus will be on helping organizations reduce the time, cost, and complexity of drug development while improving research quality, operational efficiency, and patient outcomes.
As pharmaceutical companies increasingly adopt AI-driven research, advanced analytics, and digital technologies, strategic transformation has become critical to accelerating scientific discovery and bringing new therapies to market faster.
Looking Ahead
Luke's appointment reflects EY's continued focus on expanding its expertise in life sciences consulting and digital transformation.
His experience in R&D strategy, automation, and AI positions him to help clients navigate evolving industry challenges while driving innovation across the pharmaceutical research and development ecosystem.
About EY
EY is a global professional services organization providing assurance, consulting, strategy, tax, and transaction services. Through its life sciences and healthcare practice, EY helps organizations accelerate innovation, modernize operations, and leverage emerging technologies such as AI to improve business performance and patient outcomes.